Related references
Note: Only part of the references are listed.Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
Svenja Weiss et al.
NATURE COMMUNICATIONS (2022)
Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry
Belinda L. Spillings et al.
CELL REPORTS (2022)
Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites
Ying Sheng et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients
Jeromine Klingler et al.
ISCIENCE (2022)
Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients
Cho-Chin Cheng et al.
VACCINES (2022)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
Jie Hu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
Guillermo Valenzuela Nieto et al.
SCIENTIFIC REPORTS (2021)
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
Nikolas Friedrich et al.
NATURE COMMUNICATIONS (2021)
Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases
Alex F. Tang et al.
VACCINES (2021)
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Jeromine Klingler et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
Emma Parker Miller et al.
VIRUSES-BASEL (2021)
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
Meredith Phelps et al.
FRONTIERS IN IMMUNOLOGY (2021)
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
Ritsuko Kubota-Koketsu et al.
BIOLOGICS-TARGETS & THERAPY (2021)
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity
Jennifer Lai et al.
VACCINE (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes
Chitra Upadhyay et al.
PLOS PATHOGENS (2020)
Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon
Lily Liu et al.
VIROLOGY (2019)
Immune Correlates of Disease Progression in Linked HIV-1 Infection
Michael Tuen et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler et al.
FRONTIERS IN IMMUNOLOGY (2019)
ConA-Like Lectins: High Similarity Proteins as Models to Study Structure/Biological Activities Relationships
Benildo S. Cavada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CD4 occupancy triggers sequential pre-fusion conformational states of the HIV-1 envelope trimer with relevance for broadly neutralizing antibody activity
Branislav Ivan et al.
PLOS BIOLOGY (2019)
Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates
Zakiya M. Qualls et al.
JOURNAL OF VIROLOGY (2018)
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Nicole L. Yates et al.
JOURNAL OF VIROLOGY (2018)
Glycointeractions in bacterial pathogenesis
Jessica Poole et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
Chitra Upadhyay et al.
PLOS PATHOGENS (2018)
Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
Haoqing Wang et al.
CELL HOST & MICROBE (2018)
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
Constantinos Kurt Wibmer et al.
NATURE COMMUNICATIONS (2018)
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
Catarina E. Hioe et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimized protocol for detection of native, full-length HIV-1 envelope on the surface of transfected cells
J. B. Altman et al.
HEALTH SCIENCE REPORTS (2018)
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
Jeong Hyun Lee et al.
IMMUNITY (2017)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Native-like Env trimers as a platform for HIV-1 vaccine design
Rogier W. Sanders et al.
IMMUNOLOGICAL REVIEWS (2017)
Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer
Rebecca L. R. Powell et al.
JOURNAL OF VIROLOGY (2017)
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang et al.
JOURNAL OF VIROLOGY (2017)
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
Daniel W. Kulp et al.
NATURE COMMUNICATIONS (2017)
Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure
Mohammed S. Aiyegbo et al.
PLOS ONE (2017)
Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions
Anush Arakelyan et al.
SCIENTIFIC REPORTS (2017)
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
Susan Zolla-Pazner et al.
JOURNAL OF VIROLOGY (2016)
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women
Nonhlanhla N. Mkhize et al.
AIDS (2016)
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens
Ann J. Hessell et al.
JOURNAL OF IMMUNOLOGY (2016)
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides
Ann J. Hessell et al.
VACCINE (2016)
Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance
Dorota Kmiec et al.
MBIO (2016)
Broadly Neutralizing Antibodies for HIV Eradication
Kathryn E. Stephenson et al.
CURRENT HIV/AIDS REPORTS (2016)
The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel
Ruimin Pan et al.
JOURNAL OF VIROLOGY (2015)
A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
Liuzhe Li et al.
MOLECULAR IMMUNOLOGY (2015)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Discrete partitioning of HIV-1 Env forms revealed by viral capture
Daniel J. Stieh et al.
RETROVIROLOGY (2015)
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
George K. Lewis et al.
VIRUSES-BASEL (2015)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry
Oliver F. Brandenberg et al.
PLOS PATHOGENS (2015)
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Anthony P. West et al.
CELL (2014)
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Emilia Falkowska et al.
IMMUNITY (2014)
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
Claudia Blattner et al.
IMMUNITY (2014)
Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
Chitra Upadhyay et al.
JOURNAL OF VIROLOGY (2014)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera et al.
NATURE (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies
Sara Carbonetti et al.
PLOS ONE (2014)
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
Devin Sok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation
Oliver F. Brandenberg et al.
RETROVIROLOGY (2014)
Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors
Preston S. K. Ng et al.
NATURE COMMUNICATIONS (2014)
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
Susan Zolla-Pazner et al.
EBIOMEDICINE (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
HIV-1 Vpu Does Not Degrade Interferon Regulatory Factor 3
Dominik Hotter et al.
JOURNAL OF VIROLOGY (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines
Rajnish Kumar et al.
VACCINE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Peter D. Kwong et al.
IMMUNITY (2012)
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages
Christina Ochsenbauer et al.
JOURNAL OF VIROLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
Miroslaw K. Gorny et al.
VIROLOGY (2012)
The B Cell Response Is Redundant and Highly Focused on V1V2 during Early Subtype C Infection in a Zambian Seroconverter
Rebecca M. Lynch et al.
JOURNAL OF VIROLOGY (2011)
Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities
Chavdar Krachmarov et al.
JOURNAL OF VIROLOGY (2011)
Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected
Ema T. Crooks et al.
JOURNAL OF VIROLOGY (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Evolutionary Forces Shaping the Golgi Glycosylation Machinery: Why Cell Surface Glycans Are Universal to Living Cells
Ajit Varki
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIVSF162P4
James E. Robinson et al.
JOURNAL OF VIROLOGY (2010)
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
Catarina E. Hioe et al.
PLOS ONE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Lipid binding properties of 4E10, 2175, and WR304 monoclonal antibodies that neutralize HIV-1
Gary R. Matyas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
Katie L. Davis et al.
JOURNAL OF VIROLOGY (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
Susan Zolla-Pazner et al.
VIROLOGY (2009)
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination
Katie L. Davis et al.
VIROLOGY (2009)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120
Maria Luisa Visciano et al.
VIROLOGY (2008)
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes
S. Munir Alam et al.
JOURNAL OF IMMUNOLOGY (2007)
Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence
W. J. Honnen et al.
JOURNAL OF VIROLOGY (2007)
Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1
Miroslaw K. Gorny et al.
JOURNAL OF VIROLOGY (2006)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner
CJ Saunders et al.
JOURNAL OF VIROLOGY (2005)
Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
MK Gorny et al.
JOURNAL OF VIROLOGY (2005)
Folding of HIV-1 Envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage
A Land et al.
FASEB JOURNAL (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
G Stiegler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Identification of the cellular receptor for anthrax toxin
KA Bradley et al.
NATURE (2001)
The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding
Y Li et al.
VIROLOGY (2000)
Share Paper
